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Background and Purpose  This study was designed to investigate clinical and pathologic 
characteristics of five Korean patients with RYR1-related congenital myopathy (CM).
Methods  Five patients from unrelated families were diagnosed with RYR1-related CM via di-
rect or targeted sequencing of RYR1. Their clinical, mutational, and pathologic findings were 
then analyzed.
Results  Seven different mutations were identified, including two novel mutations: c.5915A> 
T and c.12250C>T. All of the patients presented at infancy with proximal dominant weakness 
and delayed motor milestones. Other clinical findings were scoliosis in three patients, winged 
scapula in two, hip dislocation in one, and pectus excavatum in one. Ophthalmoplegia was ob-
served in one patient with a novel recessive mutation. Two of three muscle specimens revealed 
a myopathic pattern with core.
Conclusions  We have identified a novel compound heterozygous RYR1 mutation and demon-
strated clinical and pathologic findings in five Korean patients with RYR1-related CM.
Key Words   myopathy, RYR1, ryanodine receptor 1, central core disease. 
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with RYR1-Related Congenital Myopathy
INTRODUCTION
Congenital myopathies (CMs) are a heterogeneous group of inherited muscle disorders 
that are divided into subtypes based on the predominant histopathologic findings, namely 
nemaline rods, cores, central nuclei, or fiber-type disproportion.1,2 However, the clinical 
and pathologic phenotypes are not always correlated with the genotype in CM. The same ge-
netic mutation can give rise to different phenotypes, and more than two genes can cause the 
same histopathologic findings.3 Additionally, the application of next-generation sequencing 
improves the molecular diagnosis of genetic disorders, including CM. Mutations in more than 
45 causative genes have so far been implicated in CM,4 and recent studies have frequently 
defined subtypes based on causative genes and analyzed the clinical and pathologic genetic 
subtypes.1,5,6 
RYR1-related myopathy is one of the most common CMs.5-8 RYR1 encodes ryanodine re-
ceptor 1 (RYR1), which is the principal channel for releasing calcium in the sarcoplasmic 
reticulum plays a crucial role in excitation-contraction coupling. The classical clinical fea-
tures of RYR1-related myopathy have been recognized as central core disease (CCD) and 
malignant hyperthermia (MH) susceptibility. However, recently reported RYR1-related my-
opathies include forms of not only CCD but also multiminicore disease, centronuclear my-
opathy, type-1 predominance, and congenital fiber-type disproportion (CFTD).9 We eval-
uated the characteristics of RYR1-related myopathy in a Korean population by analyzing 
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clinical, pathologic, and genetic findings obtained from five 
unrelated patients with RYR1 mutations.
METHODS
Subjects
We reviewed the medical records of a myopathy database from 
January 2002 to December 2014. Five unrelated patients with 
RYR1 mutations (ID25, ID37, ID45, ID131, and ID185) were 
identified and included in this study. We have reported on 
these patients previously, but did not demonstrate detailed clin-
ical and pathologic phenotypes.10 The present research protocol 
was approved by the Institutional Review Board of Gangnam 
Severance Hospital, Korea (IRB number: 3-2017-0051). All 
participants had previously been required to sign an informed-
consent document for the use of their data genetic analysis.
Variant analysis
All variants were classified according to the American College 
of Medical Genetics and Genomics/Association for Molecular 
Pathology (ACMG/AMP) guidelines.11 We filtered polymor-
phisms found in the Korean population (n=298) while also 
using public databases [dbSNP 135 and 1000 Genome project 
SNP (2014 October release)] from East Asian, South Asian, 
and all-population databases. Deleterious effects of the vari-
ants were supported by multiple lines of computational evi-
dence including from SIFT, PolyPhen-2, Mutation Assessor, 
Mutation Taster, FATHMM, and GERP++. Further informa-
tion is available elsewhere.10
Phenotype assessment
Clinical, laboratory, and pathologic data were obtained ret-
rospectively by reviewing medical records. Clinical informa-
tion included assessments of age at symptom onset, muscle 
impairments, respiratory distress, limitations of extraocular 
muscles, facial deformity, winged scapula, scoliosis, joint con-
tractures, and physical disability. Laboratory analyses included 
the serum creatine kinase (CK) level. Muscle imaging with 
CT fat measurements was available for one patient.
Pathologic assessment
Muscle biopsies were performed in three patients, and one pa-
tient had been examined previously at other hospital. Three 
muscle specimens obtained at our center were taken from the 
biceps brachii (ID185), paraspinal muscle (ID37), and vastus 
lateralis (ID131). Frozen muscle sections (5-μm thick) obtained 
from all muscle specimens were stained with hematoxylin and 
eosin (H&E), modified Gomori trichrome (modified GT), 
and reduced nicotinamide adenine dinucleotide-tetrazolium 
reductase (NADH-tr). Muscle specimens were also analyzed 
by immunohistochemistry using antibodies against the C-ter-
minus, rod, and N-terminus of dystrophin (Leica Microsys-
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Fig. 1. Pedigrees of the five patients with RYR1-related congenital myopathies.  
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tems, Newcastle upon Tyne, UK), dysferlin (Leica Microsys-
tems), α-sarcoglycan (Leica Microsystems), β-sarcoglycan 
(Leica Microsystems), γ-sarcoglycan (Leica Microsystems), 
δ-sarcoglycan (Leica Microsystems), α-dystroglycan (Milli-
pore, Billerica, MA, USA), and caveolin (BD Biosciences, San 
Diego, CA, USA).
RESULTS
Mutational analysis 
We identified seven different RYR1 mutations in five patients 
from unrelated families, which were classified into pathogenic 
or likely pathogenic according to ACMG/AMP guidelines 
(Fig. 1).11 All of the RYR1 variants that were pathogenic or 
likely pathogenic were missense variants, and they included 
two novel variants: c.5915A>T and c.12250C>T. Four patients 
(ID25, ID37, ID131, and ID185) carried previously reported 
pathogenic variants,12-14 among which ID131 carried com-
pound heterozygous variants (c.2287G>A and c.10817T>C). 
The proband’s parents were both clinically healthy. Genetic 
testing revealed that the proband’s father carried the heterozy-
gous c.2287G>A variant, while his mother carried the hetero-
zygous c.10817T>C variant. 
The other patient (ID45) carried two novel compound het-
erozygous RYR1 mutations: c.5915A>T and c.12250C>T. Se-
quencing of RYR1 in the family members revealed that the 
proband’s father was heterozygous for the c.12250C>T vari-
ant, while her sister was heterozygous for the c.5915A>T vari-
ant. These family members with heterozygous variants were 
clinically healthy. The two novel variants (c.12250C>T and 
c.5915A>T) were classified as likely pathogenic according to 
ACMG criteria, representing two each in the moderate and 
supporting categories, respectively. The c.12250C>T variant 
was included in the CCD-MH hotspots and absent from the 
control. The c.5915A>T variant was absent from the control 
and detected in a trans arrangement with the c.12250C>T 
variant. Deleterious effects of these novel variants were sup-
ported by multiple sources of computational evidence. We also 
considered how the features of patient ID45 were compatible 
with the phenotype of recessive RYR1-related CM. 
Clinical manifestations
The clinical features of the five patients with RYR1 mutations 
are summarized in Table 1. All of the patients presented at 
infancy, and delayed motor milestones including sitting, 
standing, and gait were observed consistently, after which all 
patients had achieved independent gait. However, two pa-
tients (ID37 and ID45) became wheelchair dependent at the 
ages of about 10 and 25 years, respectively. 
Three patients (ID185, ID25, and ID37) carrying a domi-
nant variant in the C-terminal hotspot demonstrated the clini-
cal phenotype that was previously associated with typical CCD, 
comprising proximal weakness affecting predominantly the 
hip girdle, with sparing of extraocular muscles. Two patients 
(ID37 and ID185) showed scoliosis, among which patient 
ID37 had severe scoliosis (Fig. 2) with respiratory difficulty 
and had undergone surgery for scoliosis at the age of 8 years. 
Although the respiratory function of that patient improved 
after surgery, she had frequently received interventions for 
respiratory rehabilitation.
Two patients (ID45 and ID131) carrying compound hetero-
zygous variants demonstrated facial muscle weakness. Patient 
ID131 presented with floppy infant syndrome, and had pectus 
excavatum. Although that patient had bulbar muscle weakness, 
he did not require a nasogastric tube. Patient ID45 showed se-
vere features including facial dysmorphism, scoliosis (Fig. 2), 
and respiratory distress, and was the only patient to exhibit 
ophthalmoplegia. This patient experienced respiratory diffi-
culty at 33 years of age, and required nocturnal noninvasive 
ventilation.
The serum CK level was within normal limits for all patients. 
None of the five patients had a previous medical history of 
MH. Muscle CT had been conducted in one patient (ID185), 
which revealed typical clinical features of CCD and a domi-
nant RYR1 mutation. The results revealed muscle atrophy 
and fatty infiltration in the lower extremity with a selective 
involvement pattern–the rectus femoris and adductor longus 
muscles were spared in the thigh, but the soleus was strongly 
affected in the calf (Fig. 2)–that was consistent with previous 
findings for muscle imaging in RYR1-related myopathy.15 
Histopathologic examination
Muscle biopsies were performed in three patients (ID37, ID 
185, and ID131). H&E staining demonstrated wide variations 
in fiber size, degenerative fibers, and increased interstitial fi-
brosis (Fig. 3A-C). Two muscle specimens from patients ID37 
and ID185 showed well-demarcated (Fig. 3D) and ill-defined 
(Fig. 3E) central cores on NADH-tr staining. Modified GT 
staining did not demonstrate any rimmed vacuoles, nemaline 
rods, ragged red fibers, or other granular materials (Fig. 3F). 
Immunohistochemistry of the muscle specimens showed nor-
mal expression levels of dystrophin, sarcoglycan (α, β, γ, and δ), 
dysferlin, α-dystroglycan, and caveolin in all three patients. 
DISCUSSION
The present study identified seven pathogenic or likely patho-
genic variants in five Korean patients. We believe that these 
gene variants were the underlying cause of myopathy in all five 
patients. Four patients carried previously reported pathogen-
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ic variants, while patient ID45 carried two novel compound 
heterozygous RYR1 variants: c.5915A>T and c.12250C>T. 
There have been a few reports on RYR1 mutations in Ko-
rea. Fig. 4 summarizes the variants reported as pathogenic or 
likely pathogenic; all of the reported variants are missense vari-
ants including two variants in a cis arrangement. These two 
variants had been reported in an MH family with multimini-
core myopathy.16 Most of the patients with MH susceptibility 
carried a dominant mutation. The reported phenotypes of 
RYR1-related myopathies comprised three cases of CCD, two 
cases of CFTD, and one case of muscular dystrophy. The pa-
tients with CCD and one patient with CFTD had a dominant 
mutation in the C-terminal hotspot. The other patient with 
CFTD and a patient with muscular dystrophy had a com-
pound heterozygous mutation.14,17-20
Dominant variants (c.14693T>C, c.14582G>A, and c.14759C> 
A) in the C-terminal hotspot of our patients were reported 
previously as being related to CCD. The c.14582G>A (p.
R4861H) and c.14693T>C (p.I4898T) variants have been re-
ported in a CCD cohort from European countries.21 In addi-
tion, all of the dominant variants (c.14693T>C, c.14582G>A, 
and c.14759C>A) have been reported previously in a Japa-
nese cohort that showed muscle pathology characterized by 
the presence of distinct cores in almost all type-1 fibers, and 
type-2 fiber deficiency.12 
Three of the present patients (ID185, ID25, and ID37) car-
rying dominant variants (c.14693T>C, c.14582G>A, and 
c.14759C>A) in the C-terminal hotspot that presented during 
infancy showed proximal dominant weakness and delayed 
motor milestones. In terms of skeletal manifestations, two pa-
tients (ID185 and ID37) carrying variants c.14693T>C and 
c.14759C>A showed scoliosis, with patient ID37 exhibiting 
accompanying respiratory impairment and having under-
gone scoliosis surgery. That patient required wheelchair am-
bulation after the surgery, which contrasts with a prior report 
of all patients who received scoliosis surgery maintaining 
their previous motor abilities.6 Skeletal manifestations were 
commonly (50–70%) accompanied by weakness in a cohort 
A  B  C  
Fig. 2. Radiologic findings of three patients with RYR1 mutations. Whole-spine-bending X-ray of patient ID37 showed severe scoliosis at 7 years 
old (A). Scoliosis was also observed in a whole-spine X-ray of patient ID45 at 33 years old (B). Muscle CT fat-scan imaging of patient ID185 at 23 
years old (C) revealed fatty infiltration in the lumbar paraspinal and gluteus maximus muscles. The posterior compartments of the thigh, rectus fem-
oris, and adductor longus were spared, while the most-affected muscle in the calf was the soleus.
www.thejcn.com  63
Jeong HN et al. JCN
with RYR1-related CM. In these cohorts, patients with the 
c.14582G>A and c.14693T>C variants showed skeletal ab-
normalities including contracture, dislocation, scoliosis, and 
lordosis.12,22 When compared with our cases, a Japanese pa-
tient carrying the c.14693T>C variant demonstrated more-
severe features than in our case, including floppy infant syn-
drome, respiratory insufficiency, and generalized weakness. In 
contrast, another Japanese patient carrying the c.14759C>A 
variant showed no skeletal abnormality and milder features 
than in our case.12 Similarly, a previous Korean study of RYR1-
A  
D 
B  
E  
C  
F  
Fig. 3. Pathologic findings of three patients with RYR1 mutations. Hematoxylin and eosin staining demonstrated wide variations in fiber size, de-
generative fibers, and increased interstitial fibrosis (A: ID37, ×400, B: ID185, ×200, C: ID131, ×400). Two muscle specimens exhibited well-demarcat-
ed (D) and ill-defined (E) central cores on nicotinamide adenine dinucleotide-tetrazolium reductase staining (D: ID37, ×400, E: ID185, ×200). Modified 
Gomori trichrome staining did not demonstrate any rimmed vacuoles, nemaline rods, ragged red fibers, or other granular materials (F: ID37, ×400).
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Fig. 4. Locations of RYR1 mutations and phenotypes in the reported Korean patients. Schematic representation of the RYR1 protein. SPRY do-
mains are protein–protein interaction motifs which are first identified in tyrosine kinase spore lysis A and mammalian RyRs. ‡ Variants found in a 
cis arrangement, *, †, §, ¶ Variants that are compound heterozygous mutations, ◆Variants found in our patients with RYR1-related congenital my-
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related CCD patients carrying dominant variants including the 
C-terminal hotspot found mild features presenting at child-
hood without skeletal deformity.19
Advances in the understanding of novel pathogenic mech-
anisms, in particular underlying recessive RYR1-related my-
opathies, have expanded the phenotypical spectrum. Accord-
ing to previous studies, patients with CM associated with 
recessive RYR1 mutations have a tendency for earlier and more-
severe presentations compared to patients with dominant mu-
tations.23 In accordance with previous reports, our cases (ID45 
and ID131) with recessive variants demonstrated severe pre-
sentations.
Among recessive variants, the c.10817T>C (p.L3606P) vari-
ant was detected in a trans arrangement with the c.178G>A 
(p.D60N) variant in a Japanese CCD cohort.12 The reported 
case had presented at infancy with proximal dominant weak-
ness, delayed motor milestones, and lordosis.12 In contrast, our 
case carrying the c.10817T>C (p.L3606P) and c.2287G>A 
(p.V763M) variants in a trans arrangement tended to have an 
earlier and more-severe presentation compared to the Japa-
nese patient–presenting with floppy infantile syndrome, facial 
weakness, winged scapulae, and pectus excavatum. Regarding 
another variant, c.2287G>A (p.V763M) was reported in a trans 
arrangement with c.1654C>T (p.A552T) in a Korean muscu-
lar dystrophy cohort. The clinical features of that patient in-
cluded weakness, ankle contracture from infancy, and scoli-
osis.14
The clinical phenotype of our patient carrying two novel 
variants (c.5915A>T and c.12250C>T) was more severe 
than those of other patients, and included ophthalmoplegia. 
According to previous reports of recessive mutations, oph-
thalmoplegia was reported more frequently in patients who 
had at least one hypomorphic allele. Conversely, there was no 
significant association between ophthalmoplegia and muta-
tion position. Regarding pathologic findings, ophthalmople-
gia may be associated with internal/central nucleation or a 
multiminicore-like pathology.9,23
Two muscle specimens obtained from patients ID37 and 
ID185 with the C-terminal dominant variant showed core my-
opathy, which is consistent with common pathologic findings 
previously reported for RYR1-associated myopathy. Muscle 
specimens obtained from a patient (ID131) at 3 years of age 
carrying a recessive RYR1 variant revealed subtle myopathic 
changes without core. Taking into account that subsequent bi-
opsies showed the gradual development of cores in RYR1-re-
lated myopathy,22 we can speculate that this pathologic find-
ing is associated with the age at diagnosis.
It is unfortunate that there is a dearth of information on 
all patients with respect to MH susceptibility traits such as 
exertional myalgia, rhabdomyolysis, and in vitro contracture 
testing, and no study has examined RYR1 protein expression. 
According to a recent study, exertional rhabdomyolysis or 
myalgia may be a more-common manifestation of MH-relat-
ed RYR1 mutations than actual MH itself.24 The huge tetramer-
ic structure of RYR1 makes it highly likely that the genotype-
phenotypical spectrum will be expanded further. In conclusion, 
diagnosing and verifying the pathogenicity of genetic variants 
in RYR1-related myopathies requires a combined approach that 
integrates clinical, histopathologic, muscle imaging, and ge-
netic findings. 
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